当前位置:公众访问 >页面
简体中文 / English
1.Screening
1.Management for Progress
2.Inclusion Criteria

1. Patients with either II-degree debrided burn wound or donor site

Patients who replies "No" to any of the above questions will not enter the study

3. Ages between 18~65 years old

Date

yyyy-mm-dd

Doctor's signature

3.Exclusion Criteria

Patients who replies "Yes" to any of the above questions will not enter the study

Doctor's signature

Date

yyyy-mm-dd

2.Baseline
1.Management for Progress
2.General Information

Other diseases

If yes, please describe

History of allergic disease

If yes, please describe

If yes, please describe

If yes, please describe

Doctor's signature

Systolic pressure (SP)

mmHg

Date

yyyy-mm-dd

Diastolic pressure (DP)

mmHg

Name of Drug

End Date

Respiratory rate

次/分

Grouping

Start Date

Pulse rate

次/分

Marital status

Route of Administration

Dosage per Day

Date of birth

yyyy-mm-dd

Education level

3.Physical Examination

Wound Bed (bleeding)

Wound Bed (exudation)

Wound Bed (erythema)

Wound Location

Signs and Symptoms

Wound Surface Area

cm2

Wound Type

4.Lab Investigations

Uric acid

μmol/L

Creatinine

μmol/L

Urea nitrogen

mmol/L

Serum albumin

g/L

Serum bilirubin

μmol/L

AST

U/L

ALT

U/L

Urine protein

g/L (或定性)

Urine red cell

个/μL (或定性)

Urine WBC

个/μL (或定性)

PLT

X10*9/L

Hb

g/L

RBC

X10^12/L

WBC

X10*9/L

Routine Urinalysis

Routine Blood Test

Date of test

Date of examination

yyyy-mm-dd

Liver Function Test

Date of test

yyyy-mm-dd

Renal Function Test

Date of test

yyyy-mm-dd

3.In the process of the treatment
1.Treatment Record
4.At the end of the treatment
1.Management for Progress
5.SOPs
1.Treatment SOP
6.Research team
1.Institutions
7.Design, Methods
1.Calculations of sample size